title: Neuroprotection after cerebral ischemia.
abstract: Cerebral ischemia, a focal or global insufficiency of blood flow to the brain, can arise through multiple mechanisms, including thrombosis and arterial hemorrhage. Ischemia is a major driver of stroke, one of the leading causes of morbidity and mortality worldwide. While the general etiology of cerebral ischemia and stroke has been known for some time, the conditions have only recently been considered treatable. This report describes current research in this field seeking to fully understand the pathomechanisms underlying stroke; to characterize the brain's intrinsic injury, survival, and repair mechanisms; to identify putative drug targets as well as cell-based therapies; and to optimize the delivery of therapeutic agents to the damaged cerebral tissue.
authors.affiliation: Neuroscience Institute, Department of Neurobiology, Morehouse School of Medicine, Atlanta, GA, USA.
authors.forename: Shobu
authors.initials: S
authors.lastname: Namura
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Ooboshi
authors.forename: Jialing
authors.initials: J
authors.lastname: Liu
authors.forename: Midori A
authors.initials: MA
authors.lastname: Yenari
mesh_terms: D001921:Brain / Q000473:pathology / Q000503:physiopathology; D002545:Brain Ischemia / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D059906:Neuroimaging; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D033581:Stem Cell Transplantation; D020521:Stroke / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*
chemical_list: D018696:Neuroprotective Agents